INTRODUCTION METHODS
Gout, a common arthritis, causes impairment to a patient's quality of life and is a significant burden to the health-care system. 1 To further understand the burden of gout in a Canadian primary health care setting, gout patients were compared to gout-free patient profiles.
Objectives:
• Compare the patient profiles (comorbidities, lab test results) of gout patients compared to gout-free patients
• Compare the primary health care resource utilization (total # of lab tests utilized, # of specialist referrals, # of sick notes) of gout patients compared to goutfree patients
Study Design
This retrospective study used data extracted from IMS Evidence 360 EMR Canada, a primary care electronic medical records database in Ontario, Canada
Study Population
Inclusion Criteria:
1. Male and Female > 18 years at index date 2. Active in the EMR for the entire study period 3. Gout patients were selected if they had ≥1 gout diagnoses (ICD-9 274.x) OR ≥1 gout medication* claim between July 1, 2008 -June 30, 2012 4. Gout-free patients were selected if they had no record of gout diagnosis or gout medication claim within all available EMR history Selected Exclusion Criteria:
1. ≥1 oncology diagnosis or ≥1 oncology medication** Gout patients were matched 1:5 to gout-free patients based on demographics and comorbidities using an adapted version of the Charlson Comorbidity Index (CCI). 2 All patients were followed for two years post-index date. Costs were limited to primary care physician visits. A cohort of 676 gout patients ( Figure 1 ) and 3,380 gout-free patients were identified in the EMR database.
METHODS (Continued) RESULTS

RESULTS (Continued)
The utilization of healthcare resources during the two year period was significantly different between gout and gout-free patients for a number of variables studied (Table 1) . The gout population was well matched for age, sex and CCI to gout-free patients. In both groups, a high proportion of patients were male (77%) and the mean age was the same (58 ±15 years). The mean CCI score at baseline was 1.08 ±1.2 in both groups.
CONCLUSIONS
Over the two-year follow-up, gout patients were statistically more likely (p<0.01) to have a record of cardiovascular disease (61% vs. 40%), dyslipidemia (43% vs. 29%), diabetes (22% vs. 17%), obesity (26% vs. 14%), and chronic kidney disease (8% vs. 2%) than the gout-free cohort (Figure 2 ). Over the two year follow-up period, there were no clinically relevant differences between the two groups in blood pressure, fasting glucose, HbA1c, serum creatinine, HDL cholesterol, LDL cholesterol and triglycerides. However, having gout was associated with a statistically higher mean serum uric acid level (441 ± 107 umol/L) compared to those without gout (361 ± 84 umol/L). A history of smoking was similar between the gout and gout free patients (31% and 34% respectively). 
